METHODS	Two sequential cohorts of 40 patients each were randomized in a double-masked manner to receive 0.75 mg/ml or 1.50 mg/ml rhBMP-2 / ACS , placebo ( ACS alone ) , or no treatment in a 2:1:1 ratio .\